The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of regorafenib in metastatic medullary thyroid carcinoma (MTC) and radioactive iodine refractory differentiated thyroid carcinoma (RAIR DTC).
 
Kartik Sehgal
Honoraria - AmerisourceBergen; Binacea; Medscape; Pri-Med
Consulting or Advisory Role - Equinox Group; Exelixis; Guidepoint Global; Medscape; Scholar Rock
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Binacea; Merck; Pri-Med
 
Ruichao Shi
No Relationships to Disclose
 
Theodora Pappa
Employment - Deciphera (I); Replimune (I)
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Deciphera (I); Replimune (I)
 
Judy K Min
No Relationships to Disclose
 
Liam B Oakley
No Relationships to Disclose
 
Anne ONeill
No Relationships to Disclose
 
Michael J. Dennis
Consulting or Advisory Role - MJH Life Sciences
 
Hari Anant Deshpande
Employment - Yale Cancer Center
Honoraria - Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis
Research Funding - Deciphera; Eisai; SpringWorks Therapeutics
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Stock and Other Ownership Interests - tosk
Consulting or Advisory Role - ALX Oncology; AstraZeneca; aveo; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Coherus Biosciences; Eisai; EMD Serono; Galera Therapeutics; Genmab; GlaxoSmithKline; Merck; Merus; PDS Biotechnology; Scholar Rock
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genentech (Inst); Incyte (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Boehringer Ingelheim; Hookipa Pharma; ISA Pharmaceuticals; Nanobiotix
 
Jochen H. Lorch
Consulting or Advisory Role - BostonGene; Exelixis
Research Funding - Xencor (Inst)